Insider Stock Trading History of Morningside Venture Investments Ltd


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Morningside Venture Investments Ltd since year 2005. The trader's CIK number is 1543112. At the time of this reporting, Morningside Venture Investments Ltd is the 10% Owner of Apellis Pharmaceuticals, Inc. . (stock ticker symbol APLS). See this page for all insider trading activities at Apellis Pharmaceuticals, Inc. .

Note that in the past Morningside Venture Investments Ltd also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Morningside Venture Investments Ltd since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-03-11 APLS Apellis Pharmaceuticals, Inc. Buy 441,176 17.00 7,499,992
2018-09-21 APLS Apellis Pharmaceuticals, Inc. Buy 40,000 19.84 793,600
2018-09-20 APLS Apellis Pharmaceuticals, Inc. Buy 41,323 19.11 789,682
2018-09-19 APLS Apellis Pharmaceuticals, Inc. Buy 60,000 18.09 1,085,400
2018-09-18 APLS Apellis Pharmaceuticals, Inc. Buy 40,000 18.47 738,800
2018-09-17 APLS Apellis Pharmaceuticals, Inc. Buy 40,000 18.67 746,800
2018-06-25 KZR Kezar Life Sciences, Inc. Buy 250,000 15.00 3,750,000
2017-11-13 APLS Apellis Pharmaceuticals, Inc. Buy 575,000 14.00 8,050,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Morningside Venture Investments Ltd (10% Owner of Apellis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.